Five Years. The Same Score. Here Is the Diagnosis.

The Hologic Global Women’s Health Index sits at 54 out of 100. The same score as five years ago. After five editions of data, surveys across 144 countries, and a global surge of investment and attention in women’s health.

A flat score in the face of visible activity does not automatically signal failure. It signals the need for a better diagnosis.

The more useful question is not simply: Why hasn’t the score moved?

It is: What exactly has not moved — and why?

That is a diagnostic question. And it has a diagnostic answer.

What the data actually shows

The findings are not uniformly flat. Testing for high blood pressure reached a five-year high at 39%. Diabetes testing rose to 24%. Cancer testing climbed back from a previous low. An estimated 70 million more women received potentially life-saving tests between Year 4 and Year 5.

That progress is real. But it is not broad enough to move the overall score.

STI testing remained at 10%, unchanged since Year 1. And 1.5 billion women — more than half of the global female population — reported not being tested for any of the four tracked conditions in the past year.

The technology exists. The tests exist. The clinical rationale is not in dispute.

Something else is in the gap.

The three barriers that explain flat adoption

I have spent twenty years in healthcare commercialization watching clinically sound solutions fail to spread the way their creators expected. Low adoption is almost never one problem. It is almost always one of three structurally distinct barriers — and each requires a different intervention.

The Hologic data maps cleanly onto all three.

The Awareness Gap is an informational deficit. It exists when a woman does not know a test exists, does not know it applies to her, or does not hear about it from a source she experiences as credible. This is the only gap where more outreach is the right intervention. For a meaningful portion of the 1.5 billion women receiving no testing at all, this is likely where the work starts.

The Usability Gap is a friction deficit. It exists when the tests are available and a woman is aware of them, but the system makes access functionally difficult — by geography, cost, time, or infrastructure. The Year 5 data offers a signal here that is easy to overlook: 37% of women reported times in the past year when they could not afford food, and 31% said they could not afford shelter. Those are not social context statistics. They are access statistics. You do not solve a Usability Gap with a campaign. You solve it with system design.

The Trust Gap is a belief deficit. A woman can know a test exists, live near a facility that offers it, and still not go. Trust in healthcare does not live in a vacuum. It lives inside a woman’s broader experience of safety, dignity, and whether the institutions around her feel built for her reality. In Year 5, approximately 1 billion women still reported feeling unsafe in their communities. Women’s satisfaction with access to quality healthcare remained below Year 1 and Year 3 levels.

STI testing — flat at 10% for five consecutive years, even as other testing categories moved — suggests a barrier that information alone has not solved and convenience alone has not solved. In many contexts, that barrier is trust: shaped by stigma, fear of judgment, privacy concern, and institutional histories not easily undone by a better app. That is my inference from the pattern in the data, not a claim the report makes directly.

The diagnostic question

Every organization investing in women’s health right now is making decisions about where to place resources: which populations, which interventions, which partners.

The Hologic data should sharpen those decisions. But the data alone does not tell you what to do. It tells you where to look.

The wrong question is: Why aren’t women using these services? That framing subtly turns the problem into women’s reluctance or failure to engage.

The better question is: Which barrier is actually in the way?

If it is Awareness, build reach. If it is Usability, redesign access. If it is Trust, do the slower work of earning belief — and do not confuse visibility with credibility.

Misdiagnosing the barrier is not a neutral mistake. Treat a Trust problem as an Awareness problem, and you broadcast your credibility gap to a wider audience. Treat a Usability problem as a Trust problem, and you invest in belief-building for people who would act if the system were simply reachable. Treat an Awareness problem as a Usability problem, and you optimize a pathway that too few people know exists.

The diagnosis

Five more years of the same score is not inevitable. But it becomes more likely when we keep applying the wrong intervention to the wrong barrier.

The Hologic report offers something more valuable than a headline. It offers a map of uneven progress, persistent friction, and unresolved trust. The opportunity is not merely to do more for women’s health.

It is to diagnose more precisely.